GDC--0084, page-37

''I mentioned this to you a few weeks ago. What if Kazia releases good trial data BEFORE any credit raise?

It's not a far fetched thought...it actually could happen. '


JohnnyBlue

IMO

Cantrixil is in phase 1

GDC0084 is in phase 11a - safety dosage stage - and many collaborations for phase 1 or 2 that will take years to complete

What great results can one expect at these stages ?

Completing a phase 1 or 2 trial for safety -efficacy is hardly a company changer - hence beyond this is where the significant capital will be required for this $23m market cap nano biotech...